The many facets of CD26/dipeptidyl peptidase 4 and its inhibitors in disorders of the CNS – a critical overview

References

Abbott, C.A., Baker, E., Sutherland, G.R., and McCaugghan, G.W. (1994). Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene. Immunogenetics 40: 331–338, https://doi.org/10.1007/bf01246674.Search in Google Scholar PubMed

Abdelsalam, R.M. and Safar, M.M. (2015). Neuroprotective effects of vildagliptin in rat rotenone Parkinson’s disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways. J. Neurochem. 133: 700–707, https://doi.org/10.1111/jnc.13087.Search in Google Scholar PubMed

Abhangi, K.V. and Patel, J.I. (2022). Neuroprotective effects of linagliptin in a rotenone-induced rat model of Parkinson’s disease. Indian J. Pharmacol 54: 46–50, https://doi.org/10.4103/ijp.ijp_384_20.Search in Google Scholar PubMed PubMed Central

Al-Badri, G., Leggio, G.M., Musumeci, G., Marzagalli, R., Drago, F., and Castorina, A. (2018). Tackling dipeptidyl peptidase IV in neurological disorders. Neural Regen. Res. 13: 26–34, https://doi.org/10.4103/1673-5374.224365.Search in Google Scholar PubMed PubMed Central

Alkharsah, K.R., Aljaroodi, S.A., Rahman, J.U., Alnafie, A.N., Al Dossary, R., Aljindan, R.Y., Alnimr, A.M., and Hussen, J. (2022). Low levels of soluble DPP4 among Saudis may have constituted a risk factor for MERS endemicity. PLoS One 17: e0266603, https://doi.org/10.1371/journal.pone.0266603.Search in Google Scholar PubMed PubMed Central

Alponti, R.F., Frezzati, R.F., Barone, J.M., de Sous, A.V., and Siveira, P.F. (2011). Dipeptidyl peptidase IV in the hypothalamus and hippocampus of monosodium glutamate obese and food-deprived rats. Metabolism 60: 234–242, https://doi.org/10.1016/j.metabol.2009.12.031.Search in Google Scholar PubMed

Al-Qahtani, A.A., Lyroni, K., Aznaourova, M., Tseliou, M., Al-Anazi, M.R., Al-Ahdal, M.N., Alkahtani, S., Sourvinos, G., and Tsatsanis, C. (2017). Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ. Oncotarget 8: 9053–9066, https://doi.org/10.18632/oncotarget.14754.Search in Google Scholar PubMed PubMed Central

Alsaad, K.O., Hajeer, A.H., Al Balwi, M., Al Moaiqel, M., Al Oudah, N., Al Ajlan, A., AlJohani, S., Alsolamy, S., Gmati, G.E., Balkhy, H., et al.. (2018). Histopathology of Middle East respiratory syndrome (MERS-CoV) infection – clinicopathological and ultrastructural study. Histopathology 72: 516–524.10.1111/his.13379Search in Google Scholar PubMed PubMed Central

Angelopoulou, E. and Piperi, C. (2018). DPP-4 inhibitors: a promising therapeutic approach against Alzheimer’s disease. Am. Translatl. Med. 6: 255, https://doi.org/10.21037/atm.2018.04.41.Search in Google Scholar PubMed PubMed Central

Antonios, G., Saiepour, N., Bouter, Y., Richard, B.C., Paetau, A., Verkkoniemi-Ahola, A., Lannfelt, L., Ingelsson, M., Kovacs, G.G., Pillot, T., et al.. (2013). N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody. Acta Neuropathol. Commun. 6: 56, https://doi.org/10.1186/2051-5960-1-56.Search in Google Scholar PubMed PubMed Central

Antonyan, A., Schlenzig, D., Schilling, S., Naumann, M., Sharoyan, S., Mardanyan, S., and Demuth, H.U. (2018). Concerted action of dipeptidyl peptidase IV and glutaminyl cyclase results in formation of pyroglutamate-modified amyloid peptides in vitro. Neurochem. Int. 113: 112–119, https://doi.org/10.1016/j.neuint.2017.12.001.Search in Google Scholar PubMed

Arabi, Y.M., Harthi, A., Hussein, J., Bouchama, A., Johani, S., Hajeer, A.H., Saeed, B.T., Wahbi, A., Saedy, A., AlDabbagh, T., et al.. (2015). Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV). Infection 43: 495–501, https://doi.org/10.1007/s15010-015-0720-y.Search in Google Scholar PubMed PubMed Central

Armstrong, M.J. and Okun, M.S. (2020). Diagnosis and treatment of Parkinson disease. A review. JAMA 323: 548–560, https://doi.org/10.1001/jama.2019.22360.Search in Google Scholar PubMed

Arnold, S.E., Arvanitakis, Z., Macauley-Rambach, S.L., Koenig, A.M., Wang, H.Y., Ahima, R.S., Craft, S., Gandy, S., Buettner, C., Stoeckel, L.E., et al.. (2018). Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat. Rev. Neurol. 14: 168–181, https://doi.org/10.1038/nrneurol.2017.185.Search in Google Scholar PubMed PubMed Central

Athauda, D., Maclagan, K., Skene, S.S., Bajwa-Joseph, M., Letchford, D., Chowdhury, K., Hibbert, S., Budnik, N., Zampedri, L., Dickson, J., et al.. (2017). Exenatide once weekly versus placebo in Parkinson’s disease: a randomised, double-blind, placebo-controlled trial. Lancet 390: 1664–1675.10.1016/S0140-6736(17)31585-4Search in Google Scholar PubMed PubMed Central

Augestad, I.L., Pintana, H., Larsson, M., Krizhanovskii, C., Nyström, T., Klein, T., Darsalia, V., and Patrone, C. (2020). Regulation of glycemia in the recovery phase after stroke counteracts the detrimental effect of obesity-induced type 2 diabetes on neurological recovery. Diabetes 69: 1961–1973, https://doi.org/10.2337/db20-0095.Search in Google Scholar PubMed

Ayoub, B.M., Mowaka, S., Safar, M.M., Ashoush, N., Arafa, M.G., Michel, H.E., Tadros, M.M., Elmazar, M.M., and Mousa, S.A. (2018). Repositioning of as a once-weekly intranasal anti-Parkinsonian agent. Sci. Rep. 2018: 8959.10.1038/s41598-018-27395-0Search in Google Scholar PubMed PubMed Central

Barnes, K., Kenny, A.J., and Turner, A.J. (1994). Localization of aminopeptidase N and dipeptidyl peptidase IV in pig striatum and in neuronal and glia cell cultures. Eur. J. Neurosci. 6: 531–537, https://doi.org/10.1111/j.1460-9568.1994.tb00297.x.Search in Google Scholar PubMed

Bashir, S. and Al-Ayadhi, L.Y. (2014). Alterations in plasma dipeptidyl peptidase IV in autism: a pilot study. Neurol. Psychiatr. Brain Res. 20: 42–44, https://doi.org/10.1016/j.npbr.2014.03.001.Search in Google Scholar

Bassil, F., Fernagut, P.O., Bezard, E., and Meissner, W.G. (2014). Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: target for disease modification? Prog. Neurobiol. 118: 1–18, https://doi.org/10.1016/j.pneurobio.2014.02.005.Search in Google Scholar PubMed

Bayer, T.A. (2022). Pyroglutamate Abeta cascade as drug target in Alzheimer’s disease. Mol. Psychiatry 27: 18801885, https://doi.org/10.1038/s41380-021-01409-2.Search in Google Scholar PubMed PubMed Central

Bayram, E. and Litvan, I. (2020). Lowering the risk of Parkinson’s disease with GLP-1agonists and DPP4 inhibitors in type 2 diabetes. Brain 143: 2868–2871, https://doi.org/10.1093/brain/awaa287.Search in Google Scholar PubMed PubMed Central

Bernstein, H.G., Schön, E., Ansorge, S., Röse, I., and Dorn, A. (1987). Immunolocalization of dipeptidyl aminopeptidase (DAPIV) in the developing human brain. Int. J. Dev. Neurosci. 5: 237–242, https://doi.org/10.1016/0736-5748(87)90034-7.Search in Google Scholar PubMed

Bernstein, H.G., Steiner, J., Guest, P.C., Dobrowolny, H., and Bogerts, B. (2015). Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy. Schizophr. Res. 161: 4–18, https://doi.org/10.1016/j.schres.2014.03.035.Search in Google Scholar PubMed

Bernstein, H.G. and Keilhoff, G. (2018). Putative roles of cathepsin B in Alzheimer’s disease pathology: the good, the bad, and the ugly in one? Neural Regen. Res. 13: 2100–2101, https://doi.org/10.4103/1673-5374.241457.Search in Google Scholar PubMed PubMed Central

Bernstein, H.G., Dobrowolny, H., Keilhoff, G., and Steiner, J. (2018). Dipeptidyl peptidase IV, which probably plays important roles in Alzheimer disease (pathology), is upregulated in AD brain neurons and associates with amyloid plaques. Neurochem. Int. 114: 55–57, https://doi.org/10.1016/j.neuint.2018.01.005.Search in Google Scholar PubMed

Bertotto, B., Gerli, R., Spinozzi, F., Muscat, C., Fabietti, G.M., Crupi, S., Castelucci, G., Benedictis, F.M., De Giorgi, G., Britta, R., et al.. (1994). CD26 surface antigen expression on peripheral blood T lymphocytes from children with Down’s syndrome (trisomy 21). Scand. J. Immunol. 39: 633–636, https://doi.org/10.1111/j.1365-3083.1994.tb03424.x.Search in Google Scholar PubMed

Bir, S.C., Khan, M.W., Javalkar, V., Toledo, E.G., and Kelly, R.E. (2021). Emerging concepts in vascular dementia: a review. J. Stroke Cerebrovasc. Dis. 30: 105864, https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105864.Search in Google Scholar PubMed

Bis, J.C., DeCarli, C., Smith, A.V., van der Lijn, F., Crivello, F., Fornage, M., Debette, S., Shulman, J.M., Schmidt, H., Srikanth, V., et al.. (2012). Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat. Genet. 44: 545–551.10.1038/ng.2237Search in Google Scholar PubMed PubMed Central

Biessels, G.J., Verhagen, C., Janssen, J., van den Berg, E., Wallenstein, G., Zinman, B., Espeland, M.A., and Johansen, O.E. (2021). Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study. Diabetologia 64: 1235–1245, https://doi.org/10.1007/s00125-021-05393-8.Search in Google Scholar PubMed PubMed Central

Bishnoi, R., Hong, Y.R., Shah, C., Ali, A., Skelton, W.P.4th, Huo, J., Dang, N.H., and Dang, L.H. (2019). Dipeptidylpeptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: a Surveillance epidemiology and endpoint research Medicare study. Cancer Med. 8: 3918–3927.10.1002/cam4.2278Search in Google Scholar PubMed PubMed Central

Boonacker, E. and Van Noorden, C.J.F. (2003). The multifunctional or moonlighting protein CD26/DPPIV. Eur. J. Cell Biol. 82: 53–73, https://doi.org/10.1078/0171-9335-00302.Search in Google Scholar PubMed

Brandt, I., Lambeir, A.M., Ketelslegers, J.M., Vanderheyden, M., Scharpé, S., and Meester, I.D. (2006). Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its de-SerPro form. Clin. Chem. 52: 82–87, https://doi.org/10.1373/clinchem.2005.057638.Search in Google Scholar PubMed

Brauer, R., Wei, L., Ma, T., Athauda, D., Girges, C., Vijiaratnam, N., Auld, G., Whittlesea, C., Wong, I., and Foltynie, T. (2020). Diabetes medications and the risk of Parkinson’s disease: a cohort study of patients with diabetes. Brain 143: 3067–3076, https://doi.org/10.1093/brain/awaa262.Search in Google Scholar PubMed PubMed Central

Brooke, G.N. and Prischi, F. (2020). Structural and functional modelling of SARS-CoV-2 entry in animal models. Sci. Rep. 10: 15917, https://doi.org/10.1038/s41598-020-72528-z.Search in Google Scholar PubMed PubMed Central

Browne, P. and O´Cuinn, G. (1983). An evaluation of the role of a pyroglutamyl peptidase, a post-proline cleaving enzyme and a post-proline dipeptidyl aminopeptidase, aech purifiedfrom the soluble fraction of the guinea-pig brain, in the degradation of thytoliberin in vitro. Eur. J. Biochem. 137: 75–78, https://doi.org/10.1111/j.1432-1033.1983.tb07797.x.Search in Google Scholar PubMed

Broxmeyer, H.E., Hoggatt, J., O’Leary, H.A., Mantel, C., Chitteti, B.R., Cooper, S., Messina-Graham, S., Hangoc, G., Farag, S., Rohrabaugh, S.L., et al.. (2012). Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis. Nat. Med. 18: 1786–1796.10.1038/nm.2991Search in Google Scholar PubMed PubMed Central

Brust, P., Bech, A., Kretzschmar, R., and Bergmann, R. (1994). Developmental changes of enzymes involved in peptide degradation in isolated rat brain microvessels. Peptides 15: 1085–1088, https://doi.org/10.1016/0196-9781(94)90074-4.Search in Google Scholar PubMed

Busek, P., Stremeňová, J., Krepela, E., and Sedo, A. (2008a). Modulation of substance P signaling by -IV enzymatic activity in human glioma cell lines. Physiol. Res. 57: 443–449.10.33549/physiolres.931231Search in Google Scholar PubMed

Busek, P., Stremeňová, J., and Sedo, A. (2008b). Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human brain tumours–good or evil? Front. Biosci. 13: 2319–2326.10.2741/2846Search in Google Scholar PubMed

Busek, P., Stremeňová, J., Sromova, L., Hilser, M., Balaziova, E., Kosek, D., Trylcova, J., Strnad, H., Krepela, E., and Sedo, A. (2012). Dipeptidyl peptidase-IV inhibits independent of its enzymatic activity. Int J Biochem. Cell Biol. 44: 738–747.10.1016/j.biocel.2012.01.011Search in Google Scholar PubMed

Busse, S., Busse, M., Schiltz, K., Bielau, H., Gos, T., Brisch, R., Mawrin, C., Schmitt, A., Jordan, W., Müller, U.J., et al.. (2012). Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations? Brain Behav. Immun. 26: 1273–1279.10.1016/j.bbi.2012.08.005Search in Google Scholar PubMed

Cameron, K., Rozano, L., Falasca, M., and Aancera, R.L. (2021). Does the SARS-CoV-2 spike protein receptor binding interact effectively with the DPP4 (CD26) receptor? A molecular docking study. Int. J. Mol. Sci. 22: 700101, https://doi.org/10.3390/ijms22137001.Search in Google Scholar PubMed PubMed Central

Cardona, C.G., Pájaro, Q.L.D., Marzola, Q.I.D., Villegas, R.Y., and Salazar, M.L.R. (2020). Neurotropism of SARS-CoV 2: mechanisms and manifestations. J. Neurol. Sci. 412: 116824.10.1016/j.jns.2020.116824Search in Google Scholar PubMed PubMed Central

Chalichem, N.S.S., Kiran, P.S.S.S., and Basavan, D. (2018). Possible role of DPP4 inhibitors to promote hippocampal neurogenesis in Alzheimer’s disease. J. Drug Target 26: 670–675, https://doi.org/10.1080/1061186x.2018.1433682.Search in Google Scholar PubMed

Checler, F. and Valverde, A. (2022). Aminopeptidase A and dipeptidyl peptidase 4: a pathogenic duo in Alzheimer’s disease? Neural Regen. Res. 17: 2215–2217, https://doi.org/10.4103/1673-5374.335818.Search in Google Scholar PubMed PubMed Central

Chen, S., Zhou, M., Guo, A., Fernando, R.L., Chen, Y., Peng, P., Zhao, G., and Deng, Y. (2019). DPP4 inhibitor improves learning and memory and AD-like neurodegeneration by modulating the GLP-1 signaling. Neuropharmacology 157: 107668.10.1016/j.neuropharm.2019.107668Search in Google Scholar PubMed

Chen, K.C., Chung, C.H., Lu, C.H., Tzeng, N.S., Lee, C.H., Su, S.C., Kuo, F.C., Liu, J.S., Hsieh, C.H., and Chien, W.C. (2020). Association between the use of 4 inhibitors and the risk of dementia among patients with type 2 diabetes in Taiwan. J. Clin. Med. 9: 660.10.3390/jcm9030660Search in Google Scholar PubMed PubMed Central

Chen, C.H., Huang, S., and Fang, T.H. (2021). Involvement of rare mutations of SCN9A, DPP4, ABCA13, and SYT14 in schizophrenia and bipolar disorder. Int. J. Mol. Sci. 22: 13189, https://doi.org/10.3390/ijms222413189.Search in Google Scholar PubMed PubMed Central

Cheng, Q., Yang, Y., and Gao, J. (2020). Infectivity of human coronavirus in the brain. EBioMedicine 56: 10, https://doi.org/10.1016/j.ebiom.2020.102799.Search in Google Scholar PubMed PubMed Central

Chiazza, F., Tammen, H., Pintana, H., Lietzau, G., Collino, M., Nyström, T., Klein, T., Darsalia, V., and Patrone, C. (2018). The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by theSDF-1α/CXCR4 pathways. Cardiovasc. 19: 60.10.1186/s12933-018-0702-3Search in Google Scholar

Choi, J.A. and Kim, J.O. (2022). Middle East Respiratory Syndrome coronavirus vaccine development: updating clinical studies using platform technologies. J. Microbiol. 28: 1–9, https://doi.org/10.1007/s12275-022-1547-8.Search in Google Scholar PubMed PubMed Central

Chung, I.H., Lee, S.H., Lee, K.W., Park, S.H., Cha, K.Y., Kim, N.S., Yoo, H.S., Kim, Y.S., and Lee, S. (2005). Geneexpression analysis of cultured amniotic fluid cell with Down syndrome by DNA microarray. J. Kor. Med. Sci. 20: 82–87.10.3346/jkms.2005.20.1.82Search in Google Scholar

De Sousa, T.R., Correia, D.T., and Novais, F. (2021). Exploring the hypothesis of a schizophrenia and continuum: biological, genetic and pharmacologic data. CNS Neurol. Disord. – Drug Targets 2021, Sep 2. (Epub ahead of print).Search in Google Scholar

D’Amico, M., Di Filippo, C., Marfella, R., Abbatecola, A.M., Ferraraccio, F., Rossi, F., and Paolisso, G. (2010). Long-term inhibition of -4 in Alzheimer’s prone mice. Exp. Gerontol. 45: 202–207.10.1016/j.exger.2009.12.004Search in Google Scholar PubMed

Darsalia, V., Ortsäter, H., Olverling, A., Darlöf, E., Wolbert, P., Nyström, T., Klein, T., Sjöholm, Å., and Patrone, C. (2013). The DPP-4 inhibitor linagliptin counteracts stroke in the normal and diabetic mouse brain: a comparison with glimepiride. Diabetes 62: 1289–1296, https://doi.org/10.2337/db12-0988.Search in Google Scholar PubMed PubMed Central

Darsalia, V., Olverling, A., Larsson, M., Mansouri, S., Nathanson, D., Nyström, T., Klein, T., Sjöholm, Å., and Patrone, C. (2014). Linagliptin enhances stem cell proliferation after stroke in type 2 diabetic mice. Regul. Pept. 190–191: 25–31.10.1016/j.regpep.2014.05.001Search in Google Scholar PubMed

Darsalia, V., Larsson, M., Lietzau, G., Nathanson, D., Nyström, T., Klein, T., and Patrone, C. (2016). Gliptin-mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon-like peptide-1 receptor. Diabetes Obes. Metabol. 18: 537–541.10.1111/dom.12641Search in Google Scholar PubMed

Darsalia, V., Johansen, O.E., Lietzau, G., Nyström, T., Klein, T., and Patrone, C. (2019). Dipeptidyl peptidase-4 inhibitors for the potential treatment of brain disorders; A mini-review with special focus on linagliptin and stroke. Front. Neurol. 10: 493, https://doi.org/10.3389/fneur.2019.00493.Search in Google Scholar PubMed PubMed Central

Deacon, C.F. (2019). Physiology and pharmacology of DDP-4 in glucose homeostasis and the treatment of type 2 diabetes. Front. Endocrinol. 10: 80, eCollection, https://doi.org/10.3389/fendo.2019.00080.Search in Google Scholar PubMed PubMed Central

De Lecea, L., Soriano, E., Criado, J.R., Steffensen, S.C., Henrikson, S.J., and Sutcliffe, J.G. (1994). Transcripts encoding a neural membrane CD26 peptidase-like protein are stimulated by synaptic activity. Brain Res. Mol. Brain Res. 25: 286–296, https://doi.org/10.1016/0169-328x(94)90164-3.Search in Google Scholar PubMed

Della Valle, B., Brix, G.S., Brock, B., Gejl, M., Landau, A.M., Møller, A., Rungby, J., and Larsen, A. (2016). Glucagon--1 analog, liraglutide, delays onset of experimental encephalitis in Lewis rats. Front. Pharmacol. 7: 433.10.3389/fphar.2016.00433Search in Google Scholar

Dendrou, C.A., Fugger, L., and Friese, M.A. (2015). Immunopathology of multiple sclerosis. Nat. Rev. Immunol. 15: 545.10.1038/nri3871Search in Google Scholar PubMed

Deng, J., Lamb, J.R., Mckeown, A.P., Miller, S., Muglia, P., Guest, P.C., Bahn, S., Domenici, E., and Rahmoune, H. (2013). Identification of altered dipeptidyl-peptidase activities as potential biomarkers for unipolar depression. J. Affect. Disord. 151: 667–672, https://doi.org/10.1016/j.jad.2013.07.015.Search in Google Scholar PubMed

Deshpande, A.D., Harris-Hayes, M., and Schootman, M. (2008). Epidemiology of diabetes and diabetes-related complications. Phys. Ther. 11: 1254–1264, https://doi.org/10.2522/ptj.20080020.Search in Google Scholar PubMed PubMed Central

Devinsky, O., Vezzani, A., O’Brien, T.J., Jette, N., Scheffer, I.E., de Curtis, M., and Perucca, P. (2018). Epilepsy. Nat. Rev. Dis. Prim. 4: 18024, https://doi.org/10.1038/nrdp.2018.24.Search in Google Scholar PubMed

Dixit, T.S., Sharma, A.N., Lucot, J.B., and Elased, K.M. (2013). Antipsychotic-like effect of GLP-1 agonist liraglutide but not DPP-IV inhibitor sitagliptin in mouse model for psychosis. Physiol. Behav. 114–115: 38–41, https://doi.org/10.1016/j.physbeh.2013.03.008.Search in Google Scholar PubMed

Douaud, G., Alfaro-Almagro, F., Arthofer, C., Wang, C., McCarthy, P., Lange, F., Andersson, J.L.R., Griffanti, L., Duff, E., et al.. (2022). SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604: 967–707, https://doi.org/10.1038/s.41586-022-04569-5.Search in Google Scholar

Drosten, C., Seilmaier, M., Corman, V.M., Hartmann, W., Scheible, G., Sack, S., Guggemos, W., Kllies, R., Muth, D., Junglen, S., et al.. (2013). Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect. Dis. 13: 745–751.10.1016/S1473-3099(13)70154-3Search in Google Scholar PubMed PubMed Central

Elbaz, E.M., Senousy, M.A., El-Tanbouly, D.M., and Sayed, R.H. (2018). Neuroprotective effect of linagliptin against cuprizone-induced demyelination and behavioural dysfunction in mice: a pivotal role of AMPK/SIRT1 and JAK2/STAT3/NF-κB signalling pathway modulation. Toxicol. Appl. Pharmacol. 352: 153–161, https://doi.org/10.1016/j.taap.2018.05.035.Search in Google Scholar PubMed

El-Marasy, S.A., Rahman, R.F.A., and Abd-Elsalam, R.M. (2018). Neuroprotective effect of vildagliptin against ischemia in rats. Naunyn-Schmiedeberg’s Arch. Pharmacol. 391: 1133–1145, https://doi.org/10.1007/s00210-018-1537-x.Search in Google Scholar PubMed

El Yacoubi, M., Vaugeois, J.M., Marguet, D., Sauze, N., Guieu, R., Costentin, J., and Fenoillet, E. (2006). Behavioural characterization of CD26 deficient mice in animal tests of anxiety and depressant-like activity. Behav. Brain Res. 171: 279–285, https://doi.org/10.1016/j.bbr.2006.04.003.Search in Google Scholar PubMed

Ermisch, A., Rühle, H.J., Landgraf, R., and Hess, J. (1985). Blood-brain barrier and peptides. J. Cerebr. Blood Flow Metabol. 5: 350–357, https://doi.org/10.1038/jcbfm.1985.49.Search in Google Scholar PubMed

Frank, G.K., Megan Shott, E., Hagman, J.O., and Mittal, V.A. (2013). Alterations in brain structures related to taste reward circuitry in ill and recovered anorexia nervosa and in bulimia nervosa. Am. J. Psychiatr. 170: 1152–1160, https://doi.org/10.1176/appi.ajp.2013.12101294.Search in Google Scholar PubMed PubMed Central

Frenssen, F., Croonenberghs, J., Van den Steene, H., and Maes, M. (2015). Prolyl endopeptidase and dipeptidyl peptidase IV are associated with externalizing and aggressive behaviours in normal and autistic adolescents. Life Sci. 136: 157–162, https://doi.org/10.1016/j.lfs.2015.07.003.Search in Google Scholar PubMed

Frerker, N., Wagner, L., Wolf, R., Heiser, U., Hoffmann, T., Rahfeld, J.U., Schade, J., Karl, T., Naim, H.Y., Demuth, H.U., et al.. (2007). Neuropeptide Y (NPY) cleaving enzymes: structural homologues of dipeptidyl peptidase 4. Peptides 28: 257–268, https://doi.org/10.1016/j.peptides.2006.09.027.Search in Google Scholar PubMed

Frisch, T., Elkjaer, M.L., Reynolds, R., Michel, T.M., Kacprowski, T., Burton, M., Kruse, T.A., Thomassen, M., Baumbach, J., and Illes, Z. (2020). Multiple Sclerosis Atlas: a molecular map of brain lesion stages in progressive multiple sclerosis. Netw. Syst. Med. 3: 122–129, eCollection 2020, https://doi.org/10.1089/nsm.2020.0006.Search in Google Scholar PubMed PubMed Central

Frölich, L., Blum-Degen, D., Bernstein, H.G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al.. (1998). Brain insulin and insulin receptors in aging and sporadic Alzheimer’. J. Neural. Transm. 105: 423–438.10.1007/s007020050068Search in Google Scholar PubMed

Frost, J.L., Le, K.X., Cynis, H., Ekpo, E., Kleinschmidt, M., Palmour, R.M., Ervin, F.R., Snigdha, S., Cotman, C.W., Saido, T.C., et al.. (2013). Pyroglutamate-3 amyloid-β deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models. Am. J. Pathol. 183: 369–381, https://doi.org/10.1016/j.ajpath.2013.05.005.Search in Google Scholar PubMed PubMed Central

Galvan, L., André, V.M., Wang, E.A., Cepeda, C., and Levine, M.S. (2012). Functional differences between direct and indirect striatal output pathways in Huntington’s disease. J. Huntingt. Dis. 1: 17–25, https://doi.org/10.3233/jhd-2012-120009.Search in Google Scholar PubMed PubMed Central

Gao, Q., Zhang, W., Tingting, L., Yang, G., Zhu, W., Chen, N., and Jin, H. (2022). Interrelationship between 2019-nCov receptor DPP4 and diabetes mellitus targets based on protein interaction network. Sci.Rep. 12: 188, https://doi.org/10.1038/s41598-021-03912-6.Search in Google Scholar PubMed PubMed Central

Garosi, V.H., Tanhaie, S., Chaboksavar, F., Kamari, T., Gheshlaghi, P.A., Toghroli, R., Soltaninezhad, S., Azizi, S.A., Yazdani, V., and Mahmoodi, F. (2021). An overview of 2019 novel coronavirusCOVID-19 pandemic: a review study. J. Educ. Health Promot.: 280, eCollection 2021.Search in Google Scholar

Gallwitz, B. (2019). Clinical use of DPP-4 inhibitors. Front. Endocrinol. 10: 389, https://doi.org/10.3389/fendo.2019.00389.Search in Google Scholar PubMed PubMed Central

Golub, Y., Schildbach, E.M., Touma, C., Kratz, O., Moll, G.H., von Hörsten, S., and Canneva, F. (2019). Role of -pituitary-adrenal axis modulation in the stress-resilient phenotype of DPP-4 deficient rats. Behav. Brain Res. 356: 243–249.10.1016/j.bbr.2018.08.029Search in Google Scholar PubMed

Golub, Y., Stonawski, V., Plank, A.C., Eichler, A., Kratz, O., Waltes, R., von Hoersten, S., Roessner, V., and Freitag, C.M. (2021). Anxiety is associated with DPPIV alterations in children with selective mutism and social anxiety disorder: a pilot. Front. Psychiatry 12: 644553, eCollection 2021.10.3389/fpsyt.2021.644553Search in Google Scholar PubMed PubMed Central

González, A., Camila, C., and Maccioni, R.B. (2021). Alzheimer’s disease: a potential diabetes type 3. Alzheimer’s Dementia 17: e058533, https://doi.org/10.1002/alz.058533.Search in Google Scholar

Guieu, R., Fenouillet, E., Devaux, C., Fajloun, Z., Carrega, L., Sabatier, J.M., Sauze, N., and Marguet, D. (2006). CD26 modulates nociception in mice via its dipeptidyl-peptidase IV activity. Behav. Brain Res. 166: 230–235, https://doi.org/10.1016/j.bbr.2005.08.003.Search in Google Scholar PubMed

Harrison, P.J., Colbourne, L., and Harrison, C.H. (2020). The neuropathology of bipolar disorder: systematic review and meta-analysis. Mol. Psychiatr. 25: 1787–1808, https://doi.org/10.1038/s41380-018-0213-3.Search in Google Scholar PubMed PubMed Central

Hartel, S., Gossrau, R., Hanski, C., and Reutter, W. (1988). Dipeptidyl peptidase (DPP) IV in rat organs. Comparison of immunohistochemistry and activity histochemistry. Histochemistry 89: 151–161, https://doi.org/10.1007/bf00489918.Search in Google Scholar PubMed

Hattori, S. (2020). Omarigliptin decreases inflammation and insulin resistance in a pleiotropic manner in patients with type 2 diabetes. Diabetol. Metab. Syndrome 12: 24.10.1186/s13098-020-00533-3Search in Google Scholar PubMed PubMed Central

Hay, P. (2020). Current approach to eating disorders: a clinical update. Intern. Med. J. 50: 24–29, https://doi.org/10.1111/imj.14691.Search in Google Scholar PubMed PubMed Central

Hibar, D.P., Adams, H.H.H., Jahanshad, N., Chauhan, G., Stein, J.L., Hofer, E., Renteria, M.E., Bis, J.C., Arias-Vasquez, A., Ikram, M.K., et al.. (2017). Novel genetic loci associated with hippocampalvolume. Nat. Commun. 8: 13624.10.1038/ncomms13624Search in Google Scholar PubMed PubMed Central

Hildebrandt, M., Rose, M., Mayr, C., Schüler, C., Reutte, W., Salama, A., and Klapp, B.F. (1999). Alterations in expression and in serum activity of dipeptidyl peptidase IV (DPP IV, CD26) in patients with eating disorders. Scand. J. Immunol. 50: 536–541.10.1046/j.1365-3083.1999.00612.xSearch in Google Scholar PubMed

Hildebrandt, M., Rose, M., Mönnikes, H., Reutter, W., Keller, W., and Klapp, B.F. (2001). Eating disorders: a role for dipeptidyl peptidase IV in nutritional control. Nutrition 17: 451–454, https://doi.org/10.1016/s0899-9007(01)00547-0.Search in Google Scholar PubMed

Hippisley-Cox, J., Young, D., Coupland, C., Channon, K.M., Tan, P.S., Harrison, D.A., Rowan, K., Aveyard, P., Pavord, I.D., and Watkinson, P.J. (2020). Risk of severe COVID-19 disease ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people. Heart 106: 1503–1511, https://doi.org/10.1136/heartjnl-2020-317393.Search in Google Scholar PubMed PubMed Central

Hong, W.J., Petell, J.K., Swank, D., Sanford, J., Hixson, D.C., and Doyle, D. (1989). Expression of dipeptidyl peptidase IV in rat tissues is mainly regulated at the mRNA levels. Exp. Cell Res. 182: 256–266, https://doi.org/10.1016/0014-4827(89)90296-6.Search in Google Scholar PubMed

Hook, G., Yu, J., Toneff, T., Kindy, M., and Hook, V. (2014). Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer’s disease therapeutic. J. Alzheimer’s Dis. 41: 129–149.10.3233/JAD-131370Search in Google Scholar PubMed PubMed Central

Hopsu-Havu, V.K. and Glenner, G.G. (1966). A new dipeptide hydrolyzing glycyl-prolyl-beta-naphthylamide. Histochemie 7: 197–201.10.1007/BF00577838Search in Google Scholar PubMed

Horgusluoglu-Moloch, E., Risacher, S.L., Crane, P.K., Hibar, D., Thompson, P.M., Saykin, J.J., and Nho, K. (2019). Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways. Sci. Rep. 9: 14498, https://doi.org/10.1038/s41598-019-50507-3.Search in Google Scholar PubMed PubMed Central

Hsiung, H.M., Smiley, D.L., Zhang, X., Zhang, L., Yan, L.Z., Craft, L., Heiman, M.L., and Smith, D.P. (2005). Potent peptide agonists for human melanocortin 3 and 4 receptors derive from enzymatic cleavages of human beta-MSH (5-22) by dipeptidyl peptidase I and dipeptidyl peptidase IV. Peptides 26: 1988–1996, https://doi.org/10.1016/j.peptides.2004.12.029.Search in Google Scholar PubMed

Hunter, L.C., O’Hare, A., Herron, W.J., Fisher, L.A., and Jones, G.E. (2003). Opioid peptides and dipeptidyl peptidase in autism. Dev. Med. Child Neurol. 45: 121–128, https://doi.org/10.1111/j.1469-8749.2003.tb00915.x.Search in Google Scholar

Ikeda, Y., Nagase, N., Tsuji, A., Kitagishi, Y., and Matsuda, S. (2021). Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer’s disease. World J. Biol. Chem. 12: 104–113, https://doi.org/10.4331/wjbc.v12.i6.104.Search in Google Scholar PubMed PubMed Central

Inagaki, N., Yang, W., Watada, H., Ji, L., Schnaidt, S., Pfarr, E., Okamura, T., Johansen, O.E., George, J.T., von Eynatten, M., et al.. (2019). Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA® trial. Diabetol. Int. 11: 129–141.10.1007/s13340-019-00412-xSearch in Google Scholar PubMed PubMed Central

Isik, A.T., Soysal, P., Yay, A., and Usarel, C. (2017). The effects of sitagliptin, a DPP-4 inhibitor, on cognitive in elderly diabetic patients with and without Alzheimer’s disease. Diabetes Res. Clin. Pract. 123: 192–198.10.1016/j.diabres.2016.12.010Search in Google Scholar PubMed

Iwabuchi, A., Kamoda, T., Saito, M., Nozue, H., Izumi, I., Hirano, T., and Sumazaki, R. (2013). Serum dipeptidyl peptidase 4 activity in children with type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab. 26: 1093–1037, https://doi.org/10.1515/jpem-2013-0122.Search in Google Scholar PubMed

Jackson, C.B., Farzan, M., Chen, B., and Choe, H. (2022). Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 23: 3–20, https://doi.org/10.1038/s41580-021-00418-x.Search in Google Scholar PubMed PubMed Central

Jain, S. and Sharma, B. (2015). Neuroprotective effect of selective DPP-4 inhibitor in experimental vascular dementia. Physiol. Behav. 152: 182–193, https://doi.org/10.1016/j.physbeh.2015.09.007.Search in Google Scholar PubMed

Jain, U. (2020). Effect of COVID-19 on the organs. Cureus 12: e9540, https://doi.org/10.7759/cureus.9540.Search in Google Scholar PubMed PubMed Central

Janecka, A., Staniszewska, R., Gach, K., and Fichna, J. (2008). Enzymatic degradation of endomorphins. Peptides 29: 2066–2073.10.1016/j.peptides.2008.07.015Search in Google Scholar PubMed

Jarmołowska, B., Bukało, M., Fiedorowicz, E., Cieślińska, A., Kordulewska, N.K., Moszyńska, M., Świątecki, A., and Kostyra, E. (2019). Role of milk-derived opioid peptides and proline dipeptidyl peptidase-4 in autism spectrum. Nutrients 11: 87.10.3390/nu11010087Search in Google Scholar PubMed PubMed Central

Jeong, S.H., Chung, S.J., Yoo, H.S., Hong, N., Jung, J., Baik, K., Lee, Y.H., Sohn, Y.H., and Lee, P.-H. (2021). Beneficial effects of dipeptidyl peptidase-4 inhibitors in diabetic Parkinson’. Brain 144: 1127–1137.10.1093/brain/awab015Search in Google Scholar PubMed

Jiang, Y., Chen, Y., Sub, H., Zhang, X., He, L., Li, J., Zhao, G., and Sun, S. (2021). MERS-CoV infection causes brain damage in human DPP4- mice through complement-mediated inflammation. J. Gen. Virol. 102: 001667.10.1099/jgv.0.001667Search in Google Scholar PubMed PubMed Central

Kadowaki, T., Wang, G., Rosenstock, J., Yabe, D., Peng, Y., Kanasaki, K., Mu, Y., Mattheus, M., Keller, A., Okamura, T., et al.. (2020). Effect of linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulfonylurea glimepiride on cardiovascular outcomes in Asians with type 2 diabetes: subgroup analysis of the randomized CAROLINA® trial. Diabetol. Int. 12: 87–100, https://doi.org/10.1007/s13340-020-00447-5.Search in Google Scholar PubMed PubMed Central

Kalaria, R.N. (2016). Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease. Acta Neuropathol. 131: 659–685, https://doi.org/10.1007/s00401-016-1571-z.Search in Google Scholar PubMed PubMed Central

Khaddaj-Mallat, R., Aldib, N., Bernard, M., Paquette, A.S., Ferreira, A., Lecordier, S., Saghatelyan, A., Flaman, L., and ElAli, A. (2021). SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein. Neurobiol. Dis. 161: 105561, https://doi.org/10.1016/j.nbd.2021.105561.Search in Google Scholar PubMed PubMed Central

Katsiki, N., Gómez-Huelgas, R., Mikhailidis, D.P., and Pérez-Martínez, P. (2021). Narrative review on clinical considerations for patients with diabetes and COVID-19: more questions than answers. Int. J. Clin. Pract. 75: e14833, https://doi.org/10.1111/ijcp.14833.Search in Google Scholar PubMed PubMed Central

Kawakita, E., Koya, D., and Kanasaki, K. (2021). CD26/DPP-4: type 2 diabetes drug target with potential influence on cancer biology. Cancers 13: 2191, https://doi.org/10.3390/cancers13092191.Search in Google Scholar PubMed PubMed Central

Kim, D.S., Choi, H.I., Wang, Y., Luo, Y., Hoffer, B.J., and Greig, N.H. (2017). A new treatment strategy for Parkinson’s disease through gut-brain axis: the glucagon-like receptor pathway. Cell Transplant. 26: 1560–1571, https://doi.org/10.1177/0963689717721234.Search in Google Scholar PubMed PubMed Central

Király, K., Kozsurek, M., Lukácsi, E., Barta, B., Alpár, A., Balázsa, T., Fekete, C., Szabon, J., Helyes, Z., Bölcskei, K., et al.. (2018). Glial cell type-specific changes in spinal 4 expression and effects of its inhibitors in inflammatory and pain. Sci. Rep. 8: 3490.10.1038/s41598-018-21799-8Search in Google Scholar PubMed PubMed Central

Kleine-Weber, H., Schroeder, S., Krüger, N., Prokscha, A., Naim, H.Y., Müller, M.A., Drosten, C., Pöhlmann, P., and Hoffmann, M (2020). Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus. Emerg. Microbes Infect 9: 155–168, eCollection 2020.10.1080/22221751.2020.1713705Search in Google Scholar PubMed PubMed Central

Klemann, C., Wagner, L., Stephan, M., and von Hörsten, S. (2016). Cut to the case: a review of CD26/dipeptidyl-4′s (DPP4) entanglement in the immune system. Clin. Exp. Immunol. 185: 1–21, https://doi.org/10.1111/cei.12781.Search in Google Scholar PubMed PubMed Central

Knopman, D.S., Amieva, H., Petersen, R.C., Chételat, G., Holtzman, D.M., Hyman, B.T., Nixon, R.A., and Jones, D.T. (2021). Alzheimerdisease. Nat. Rev. Dis. Primers 13: 33.10.1038/s41572-021-00269-ySearch in Google Scholar PubMed PubMed Central

Kosaraju, J., Chakravarthi, C., Khatwai, R.B., Dubala, A., Chinni, S., Holsinger, R.M.D., Madhunapantula, V.S.R., Nataraj, S.K.M., and Basavan, D. (2013). Saxagliptin: a dipeptidyl peptidase-4 inhibitor induced Alzheimer’s disease. Neuropharmacology 73: 291–300.10.1016/j.neuropharm.2013.04.008Search in Google Scholar PubMed

Kosaraju, J., Holsinger, R.M.D., Guo, L., and Tam, K.Y. (2017). Linagliptin, a dipeptidyl peptidase-4 inhibitor, mitigates cognitive deficits and pathology in the 3xTg-AD mouse model of Alzheimer’s disease. Mol. Neurobiol. 54: 6074–6084.10.1007/s12035-016-0125-7Search in Google Scholar PubMed

Kourtian, S., Doueid, J., Makhoul, N., Guisso, D.R., Chahrour, M., and Boustany, R.M.N. (2017). Candidate genes for inherited autism susceptibility in the Lebanese population. Sci. Rep. 30: 45336, https://doi.org/10.1038/srep45336.Search in Google Scholar PubMed PubMed Central

Krasemann, S., Haferkamp, U., Pfefferle, S., Woo, M.S., Heinrich, F., Schweizer, M., Appelt-Menzel, A., Cubukova, A., Barenberg, J., Leu, J., et al.. (2022). The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Stem Cell Reports S2213-671100650-0. 17: 307–320.10.1016/j.stemcr.2021.12.011Search in Google Scholar

Kurushina, O.V. and Barulin, A.E. (2021). Central nervous system lesions in COVID-19. Neurosci. Behav. Physiol. 12: 92–97, https://doi.org/10.1007/s11055-021-01183-2.Search in Google Scholar PubMed PubMed Central

Lee, R.H.C., Lee, R. C., Lee, M.H.H., Wu, C.Y.C., Wu, C. C., Silva, A.C.E., Couto e Silva, A., Possoi, H.E., Possoit, H., Hsieh, T.H., et al.. (2018). Cerebral ischemia and neuroregeneration. Neural Regen. Res. 13: 373–385, https://doi.org/10.4103/1673-5374.228711.Search in Google Scholar PubMed PubMed Central

Li, Y.C., Bai, W.Z., and Hashikawa, T. (2020). The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J. Med. Virol. 92: 552–555, https://doi.org/10.1002/jmv.25728.Search in Google Scholar PubMed PubMed Central

Lietzau, G., Davidsson, W., Östenson, C.G., Chiazza, F., Nathanson, D., Pintana, H., Skogsberg, J., Klein, T., Nyström, T., Darsalia, V., et al.. (2018). Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor. Acta Neuropathol. Commun. 6: 14.10.1186/s40478-018-0517-1Search in Google Scholar PubMed PubMed Central

Lietzau, G., Magni, G., Kehr, J., Yoshitake, T., Candeias, E., Duarte, A.I., Pettersson, H., Skogsberg, J., Abbracchio, M.P., Klein, T., et al.. (2020). Dipeptidyl peptidase-4 inhibitors and sulfonylureas prevent the progressive impairment of the dopaminergic system induced by diabetes during aging. Neurobiol. Aging 89: 12–23.10.1016/j.neurobiolaging.2020.01.004Search in Google Scholar PubMed

Lin, C.L. and Huang, C.N. (2016). The neuroprotective effects of the anti-diabetic drug linagliptin against Aβ-induced neurotoxicity. Neural Regen. Res. 11: 236–237.10.4103/1673-5374.177724Search in Google Scholar PubMed PubMed Central

Lindekilde, N., Scheue, S.H., Rutters, F., Knudsen, L., Lasgaard, M., Rubi, K.H., Henriksen, J.E., Kivimäki, M., Andersen, G.S., and Pouwer, F. (2022). Prevalence of type 2 diabetes in psychiatric disorders: an umbrella review with meta-analysis of 245 observational studies from 32 systematic reviews. Diabetologia 65: 440–456, https://doi.org/10.1007/s00125-021-05609-x.Search in Google Scholar PubMed

Liu, R., Cheng, J., and Wu, H. (2019). Discovery of food-derived dipeptidyl peptidase IV inhibitory peptides: a review. Int. J. Mol. Sci. 20: 463, https://doi.org/10.3390/ijms20030463.Search in Google Scholar PubMed PubMed Central

Liu, Y., Hou, B., Zhang, Y., Fan, Y., Peng, B., Liu, W., Han, S., Yin, J., He, V. (2018). Anticonvulsant agent DPP4 inhibitor sitagliptin downregulates CXCR3/RAGE pathway on seizure models. Exp. Neurol. 307: 90–98, https://doi.org/10.1016/j.expneurol.2018.06.004.Search in Google Scholar PubMed

Louis, D.N., Perry, A., Wesseling, P., Bra, D.J., Cree, I.A., Figarella-Branger, D., Hawkins, C., Ng, H.K., Pfister, S.M., Reifenberger, G., et al.. (2021). The 2021 WHO Classification of tumours of the central nervous system: a summary. Neuro Oncol. 23: 1231–1251, https://doi.org/10.1093/neuonc/noab106.Search in Google Scholar PubMed PubMed Central

Ma, M., Hasegawa, Y., Koibuchi, N., Toyama, K., Uekawa, K., Nakagawa, T., Lin, B., and Kim-Mitsuyama, S. (2015). DPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic mice. Cardiovasc. Diabetol. 14: 54, https://doi.org/10.1186/s12933-015-0218-z.Search in Google Scholar PubMed PubMed Central

Ma, Q.H., Jiang, L.F., Mao, J.L., Xu, W.X., and Huang, M. (2018). Vildagliptin prevents cognitive deficits and neuronal apoptosis in a rat model of Alzheimer’s disease. Mol. Med. Rep. 17: 4113–4119.10.3892/mmr.2017.8289Search in Google Scholar PubMed

Maes, M., De Meester, I., Scharpé, S., Desnyder, R., Ranjan, R., and Meltzer, H.Y. (1996). Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychoticdrugs. Acta Psychiatr. Scand. 93: 1–8.10.1111/j.1600-0447.1996.tb10612.xSearch in Google Scholar PubMed

Maes, M., De Meester, I., Verkerk, R., De Medts, P., Wauters, A., Vanhoof, G., Vandoolaeghe, E., Neels, H., and Scharpé, S. (1997). Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: relationships with immune-inflammatory markers. Psychoneuroendocrinology 22: 65–78, https://doi.org/10.1016/s0306-4530(96)00040-6.Search in Google Scholar PubMed

Malhi, G.S. and Mann, J.J. (2018). Depression. Lancet 392: 2299–2312, https://doi.org/10.1016/s0140-6736(18)31948-2.Search in Google Scholar

Mann, D.M.A. (1994). The pathological association between Down syndrome and Alzheimer disease. Mech. 43: 99–136.10.1016/0047-6374(88)90041-3Search in Google Scholar PubMed

Mareš, V., Stremeňová, J., Lisá, V., Kozáková, H., Marek, J., Syrůček, M., Šoula, O., and Šedo, A. (2012). Compartment- and malignance-dependent up-regulation of gamma-glutamyltranspeptidase and -IV activity in human brain gliomas. Histol. Histopathol. 27: 931–940.Search in Google Scholar

Marshall, M. (2020). How COVID-19 can damage the brain. Nature 585: 342, https://doi.org/10.1038/d41586-020-02599-5.Search in Google Scholar PubMed

Matrasova, I., Busek, P., Balaziova, E., and Sedo, A. (2017). Heterogeneity of molecular forms of dipeptidyl peptidase-IV and fibroblast activation protein in human glioblastomas. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 161: 252–260, https://doi.org/10.5507/bp.2017.010.Search in Google Scholar PubMed

Matsuyama, R., Nishiura, H., Kutsuna, S., Hayakawa, K., and Ohmagari, N. (2016). Clinical determinants of the severity of Middle East respiratory syndrome (MERS): a systematic review and meta-analysis. BMC Publ. Health 16: 1203, https://doi.org/10.1186/s12889-016-3881-4.Search in Google Scholar PubMed PubMed Central

Mayfield, K., Siskind, D., Winckel, K., Russell, A.W., Kisely, S., Smith, G., and Hollingworth, S. (2016). Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes. J. Psychopharmacol. 30: 227–236, https://doi.org/10.1177/0269881115625496.Search in Google Scholar PubMed

McGinley, M.P., Goldschmidt, C.H., and Rae-Gran, A.D. (2021). Diagnosis and treatment of multiple sclerosis. A review. JAMA 325: 765–779, https://doi.org/10.1001/jama.2020.26858.Search in Google Scholar PubMed

McIntosh, C.H., Demuth, H.U., Pospisilik, J.A., and Pederson, R. (2005). Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents? Regul. Pept. 128: 159–165, https://doi.org/10.1016/j.regpep.2004.06.001.Search in Google Scholar PubMed

Mechawar, N. and Savitz, J. (2016). Neuropathology of mood disorders: do we see the stigmata of inflammation? Transl. Psychiatry. 6: e946, https://doi.org/10.1038/tp.2016.212.Search in Google Scholar PubMed PubMed Central

Medeiros Mdos, S., Balmforth, A.J., Vaughan, P.F., and Turner, A.J. (1991). Hydrolysis of atrial and brain natriuretic peptides by the human astrocytoma clone D384 and the neuroblastoma line SH-SY5Y. Neuroendocrinology 54: 295–302, https://doi.org/10.1159/000125891.Search in Google Scholar PubMed

Mentlein, R. (1999). Dipeptidyl peptidase IV (CD26) – role in the inactivation of regulatory peptides. Regul. Pept. 85: 9–24, https://doi.org/10.1016/s0167-0115(99)00089-0.Search in Google Scholar PubMed

Mentzel, S., Dijkman, H.B.P.M., van Son, J.P.H.F., Koene, R.A.P., and Assmann, K.J. (1996). Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice. J. Histochem. Cytochem. 44: 445–461, https://doi.org/10.1177/44.5.8627002.Search in Google Scholar PubMed

Mitro, A. and De Bault, L.E. (1994). Membrane-bound proteases of the gerbil organ and plexus : an enzyme histochemical study. Acta Histochem. 96: 1–7.10.1016/S0065-1281(11)80002-4Search in Google Scholar PubMed

Monami, M., Lamanna, C., Desideri, C.M., and Mannucci, E. (2012). DPP-4 inhibitors and lipids: systematic review and meta-analysis. Adv. Ther. 29: 14–25, https://doi.org/10.1007/s12325-011-0088-z.Search in Google Scholar PubMed

Moreno, E., Canet, J., Gracia, E., Lluís, C., Mallol, J., Canela, E.I., Cortés, A., and Casadó, V. (2018). Molecular evidence of adenosine deaminase linking adenosine A2Areceptor and CD26 proteins. Front. Pharmacol. 9: 106, https://doi.org/10.3389/fphar.2018.00106.Search in Google Scholar PubMed PubMed Central

Morgello, S. (2019). Coronaviruses and the central nervous system. J. Neurovirol. 26: 459–473, https://doi.org/10.1007/s13365-020-00868-7.Search in Google Scholar PubMed PubMed Central

Mousa, S.A. and Ayoub, B.M. (2019). Repositioning of dipeptidyl peptidase-4 inhibitors and glucagon like peptide-1 agonists as potential neuroprotective agents. Neural Regen. Res. 14: 745–748, https://doi.org/10.4103/1673-5374.249217.Search in Google Scholar PubMed PubMed Central

Mulvihill, E.E. and Drucker, D.J. (2014). Pharmacology, physiology and mechanisms of action of dipeptidyl peptidase-4 inhibitors. Endocr. Rev. 35: 992–1019, https://doi.org/10.1210/er.2014-1035.Search in Google Scholar PubMed PubMed Central

Nádasdi, Á., Sinkovits, G., Bobek, I., Lakatos, B., Förhécz, Z., Prohászka, Z.Z., Réti, M., Arató, M., Cseh, G., Masszi, T. et al.. (2022). Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients. Biomarkers Med. 16: 317–330, https://doi.org/10.2217/bmm-2021-0717.Search in Google Scholar PubMed PubMed Central

Nagatsu, T. (2017). Prolyl oligopeptidase and dipeptidyl dipeptidase II/dipeptidase IV ratio in the cerebrospinal fluid in Parkinson’s disease: historical overview and future prospects. J. Neural. Transm. 124: 739–744, https://doi.org/10.1007/s00702-016-1604-8.Search in Google Scholar PubMed

Nagy, J.I., Yamamoto, T., Uemura, H., and Schrader, W.P. (1996). Adenosine deaminase in rodent median eminence: detection by antibody to the mouse enzyme and co-localization with adenosine deaminase-complexing protein (CD26). Neuroscience 73: 459–471, https://doi.org/10.1016/0306-4522(96)00049-8.Search in Google Scholar PubMed

Nahvi, R.J., Tanelian, A., Nwokafor, C., Hollander, C.M., Peacock, L., and Sabban, E.L. (2021). Intranasal neuropeptide Y as a potential therapeutic for depressive behaviour in the rodent single prolonged stress model in females. Front. Behav. Neurosci. 15: 705579, https://doi.org/10.3389/fnbeh.2021.705579.Search in Google Scholar PubMed PubMed Central

Nakaoku, Y., Saito, S., Yamamoto, Y., Maki, T., Takahashi, R., and Iha, M. (2019). The dipeptidyl peptidase-4 inhibitor linagliptin ameliorates high-fat induced cognitive decline in model mice. Int. J. Mol. Sci. 20: 2539.10.3390/ijms20102539Search in Google Scholar PubMed PubMed Central

Nassar, N.N., Al-Shorbagy, M.Y., Arab, H.H., and Abdallah, D.M. (2015). Saxagliptin: a novel antiparkinsonian approach. Neuropharmacology 89: 308–317, https://doi.org/10.1016/j.neuropharm.2014.10.007.Search in Google Scholar PubMed

Natoli, S., Oliveira, V., Calabresi, P., Maia, L.F., and Pisani, S. (2020). Does SARS-CoV invade the brain? Translational lessons from animal models. Eur. J. Neurol. 27: 1764–1773, https://doi.org/10.1111/ene.14277.Search in Google Scholar PubMed PubMed Central

Nazarova, G.A., Kolyasnikova, K.N., and Zolotov, N.N. (2012). Changes in activity of proline-specific peptidases in rat model for of Alzheimer type. Bull. Exp. Biol. Med. 153: 674–676.10.1007/s10517-012-1796-3Search in Google Scholar PubMed

Nishina, S., Yamauchi, A., Kawaguchi, T., Kaku, K., Goto, M., Sasaki, K., Hara, Y., Tomiyama, Y., Kuribayash, F., Torimura, T., and Hino, K. (2018). Dipeptidyl peptidase 4 inhibitors reduce hepatocellular carcinoma by activating lymphocyte chemotaxis in mice. Cell Mol. Gastroenterol. Hepatol. 27: 115–134, https://doi.org/10.1016/j.jcmgh.2018.08.008.Search in Google Scholar PubMed PubMed Central

O’Connor, B. and O’Cuinn, G. (1986). Post-proline dipeptidyl-aminopeptidase from synaptosomal membranes of Guinea pig brain. A possible role for this activity in the hydrolysis of His-ProN2, arising from the action of synaptosomal membrane pyroglutamate on thyroliberin. Eur. J. Biochem. 154: 329–335.10.1111/j.1432-1033.1986.tb09401.xSearch in Google Scholar PubMed

Ojha, R., Gurjar, K., Ratnakar, T.S., Mishra, A., and Prajapati, V.K. (2022). Designing of a bispecific antibody against SARS-CoV-2 spike glycoprotein targeting human entry receptors DPP4 and ACE2. Hum. Immunol. 83: 346–355, https://doi.org/10.1016/j.humimm.2022.01.004.Search in Google Scholar PubMed PubMed Central

Ohyagi, Y., Miyoshi, K., and Nakamura, N. (2019). Therapeutic strategies for Alzheimer’s disease in the view of diabetes mellitus. Adv. Exp. Med. Biol. 1128: 227–248.10.1007/978-981-13-3540-2_11Search in Google Scholar PubMed

Omar, B. and Ahrén, B. (2014). Pleiotropic mechanisms for the glucose-lowering action of DPP-4 inhibitors. Diabetes 63: 2196–2202, https://doi.org/10.2337/db14-0052.Search in Google Scholar PubMed

Paniz-Mondolfi, A., Bryc, C., Grimes, Z., Gordon, R.E., Reidy, J., Lednicky, J., Sordillo, E.M., and Fowkes, M. (2020). Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J. Med. Virol. 92: 699–702, https://doi.org/10.1002/jmv.25915.Search in Google Scholar PubMed PubMed Central

Pariyar, R., Bastola, T., Lee, D.H., and Seo, J. (2022). Neuroprotective effects of the DPP4 inhibitor vildagliptin in in vivo and in vitro models of Parkinson’s disease. Int. J. Mol. Sci. 23: 2388, https://doi.org/10.3390/ijms23042388.Search in Google Scholar PubMed PubMed Central

Parsamanesh, N., Pezeshgi, A., Hemmati, M., Jameshorani, M., and Saboory, E. (2021). Neurological of coronavirus infections: role of angiotensin-converting enzyme 2 in COVID-19. Int. J. Neurosci. 14: 1–8.10.1080/00207454.2020.1849193Search in Google Scholar PubMed

Patel, K.R., Cherian, J., Gohil, K., and Atkinson, D. (2014). Schizophrenia: overview and treatment options. PT 39: 638–645.Search in Google Scholar

Pintana, H., Apaijai, N., Chattipakorn, N., and Chattipakorn, S. (2013). DPP-4 inhibitors improve cognition and brain mitochondrial function on insulin-resistant rats. J. Endocrinol. 28: 1–11, https://doi.org/10.1530/joe-12-0521.Search in Google Scholar

Pivtoraiko, V.N., Racic, T., Abrahamson, E.E., Villemagne, V.L., Handen, B.L., Lott, I.T., Head, E., and Ikonomovic, M.D. (2021). Postmortem neocortical 3H-PiB binding and levels of unmodified and pyroglutamate Aβ in Down syndrome and sporadic Alzheimer’s. Front. Aging Neurosci. 13: 728739, eCollection 2021.10.3389/fnagi.2021.728739Search in Google Scholar PubMed PubMed Central

Pouget, J. G., Gonçalves, V.F., Spain, S.L., Finucane, H.K., Raychaudhuri, S., and Kennedy, J.L. (2016). Genome-wide association studies suggest limited immune gene enrichment in schizophrenia compared to 5 autoimmune diseases. Schizophr. Bull. 42: 1176–1184, https://doi.org/10.1093/schbul/sbw059.Search in Google Scholar PubMed PubMed Central

Preller, V., Gerber, A., Wrenger, S., Togni, M., Marguet, D., Tadje, J., Lendeckel, U., Röcken, C., Faust, J., Neubert, K., et al.. (2007). TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26. J. Immunol. 178: 4632–4640, https://doi.org/10.4049/jimmunol.178.7.4632.Search in Google Scholar PubMed

Pruzin, J.J., Nelson, P.T., Abner, E.L., and Arvanitakis, Z. (2018). Review: relationship of type 2 diabetes to human brain pathology. Neuropathol. Appl. Neurobiol. 44: 347–362, https://doi.org/10.1111/nan.12476.Search in Google Scholar PubMed PubMed Central

Qin, C.J., Zhao, L.H., Zhou, X., Zhang, H.L., Wen, W., Tang, L., Zeng, M., Wang, M.D., Fu, G.B., Huang, S., et al.. (2018). Inhibition of dipeptidyl peptidase IV prevents high fat diet-induced liver cancer angiogenesis by downregulating chemokine ligand 2. Cancer Lett. 420: 26–37, https://doi.org/10.1016/j.canlet.2018.01.064.Search in Google Scholar PubMed

Quintanilla-Sánchez, C., Salcido-Montenegro, A., González-González, J.G., and Rodríguez-Gutiérrez, R. (2022). Acute cerebrovascular events in severe and nonsevere COVID-19 patients: a systematic review and meta-analysis. Rev. Neurosci. 33: 631–639.10.1515/revneuro-2021-0130Search in Google Scholar PubMed

Raha, A.A., Chakraborty, S., Henderson, J., Mukaetova-Ladinska, E., Zaman, S., Trowsdale, J., and Raha-Chowdhury, R.R. (2020). Investigation of CD26, a potential SARS-CoV-2 receptor, as a biomarker of age and pathology. Biosci. Rep. 40: BSR 20203092, https://doi.org/10.1042/bsr20203092.Search in Google Scholar

Rahman, S.O., Kaundal, M., Salman, M., Shrivastava, A., Parvez, S., Panda, B.P., Akhter, My., Akhter, Mo., and Najm, A.K. (2020). Alogliptin reversed hippocampal insulin resistance in an amyloid-beta fibrils induced animal model of Alzheimer’s disease. Eur. J. Pharmacol. 889: 173522.10.1016/j.ejphar.2020.173522Search in Google Scholar PubMed

Raj, V.S., Mou, H., Smits, S.L., Dekkers, D.H., Muller, M.A., Dijkman, R., Muth, D., Demmers, J.A., Zaki, A., Fouchier, R.A., et al.. (2013). Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495: 251–254, https://doi.org/10.1038/nature12005.Search in Google Scholar PubMed PubMed Central

Rakhat, I.I., Kusmala, Y.Y., Handayan, D.R., Juliastut, H., Nawangsih, N., Wibowo, A., Lim, M.A., and Pranata, R. (2021). Dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in corona virus 2019 (COVID-19) – a systematic review, meta-analysis, and meta-regression. Diabetes Metab. Syndrome 15: 777–782.10.1016/j.dsx.2021.03.027Search in Google Scholar PubMed PubMed Central

Reinhold, D., Biton, A., Pieper, S., Lendeckel, U., Faust, J., Neuber, K., Bank, U., Tager, M., Ansorge, S., and Brocke, S. (2006). Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation. Int. Immunopharm. 6: 1935–1942, https://doi.org/10.1016/j.intimp.2006.07.023.Search in Google Scholar PubMed

Reinhold, D., Bank, U., Entz, D., Goihl, A., Stoye, D., Wrenger, S., Brocke, S., Thielitz, A., Stefin, S., Nordhoff, K., et al.. (2011). PETIR-001, a dual inhibitor of dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN), ameliorates experimental autoimmune encephalomyelitis in SJL/J mice. Biol. Chem. 392: 233–237, https://doi.org/10.1515/bc.2011.024.Search in Google Scholar

Reinhold, D. and Brocke, S. (2014). DPP4-directed therapeutic strategies for MERS-CoV. Lancet Infect. Dis. 14: 100–101, https://doi.org/10.1016/s1473-3099(13)70696-0.Search in Google Scholar PubMed PubMed Central

Röhnert, P., Schmidt, W., Emmerlich, P., Goihl, A., Wrenger, S., Bank, U., Nordhoff, K., Täger, M., Ansorge, S., Reinhold, D., et al.. (2012). Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APNlike proteases in cerebral ischemia. J. Neuroinflammation 9: 44, https://doi.org/10.1186/1742-2094-9-44.Search in Google Scholar PubMed PubMed Central

Röhrborn, D., Wronkowitz, N., and Eckel, J. (2015). DPP4 in diabetes. Front. Immunol. 6: 386, eCollection 2015, https://doi.org/10.3389/fimmu.2015.00386.Search in Google Scholar PubMed PubMed Central

Rosenstock, J., Kahn, S.E., Johansen, O.E., Zinman, B., Espeland, M.A., Woerle, H.J., Pfarr, E., Keller, A., Mattheus, M., Baanstra, D., et al.. (2019). Effect of vs glimepiride on major adverse cardiovascular outcomes in patients with type 2 diabetes: the CAROLINA Randomized Clinical Trial. JAMA 322: 1155–1166.10.1001/jama.2019.13772Search in Google Scholar PubMed PubMed Central

Saceleanu, V., Moreanu, M.S., Covache-Busuioc, R.A., Mohan, A.G., and Ciurea, A.V. (2022). SARS-COV-2-the pandemic of the XXI century, clinical manifestations – neurological implications. J. Med. Life 15: 319–327.10.25122/jml-2020-0151Search in Google Scholar PubMed PubMed Central

Sakakibara, S., Nakadate, K., Tanaka-Nakadate, S., Yoshida, K., Nogami, S., Shirataki, H., and Ueda, S. (2008). Developmental and spatial expression pattern of alpha- in the rat central nervous system. J. Comp. Neurol. 511: 65–80.10.1002/cne.21817Search in Google Scholar PubMed

Sarkar, T., Nargis, T.T., Tantia, O., Ghosh, S., and Chakrabarti, P. (2019). Increased plasma dipeptidyl peptidase-4 (DPP4) activity is an obesity-independent parameter for glycemic deregulation in type 2 diabetes patients. Front. Endocrinol. 10: 505, eCollection 2019, https://doi.org/10.3389/fendo.2019.00505.Search in Google Scholar PubMed PubMed Central

Sayed, N.H., Fathy, N., Kortam, M.A., Rabie, M.A., Mohamed, A.F., and Kamel, A.S. (2020). Vildagliptin attenuates Huntington’s disease through activation of GLP-1 receptor/PI3K/Akt/BDNF pathway in 3-nitropropionic acid rat model. Neurotherapeutics 17: 252–268, https://doi.org/10.1007/s13311-019-00805-5.Search in Google Scholar PubMed PubMed Central

Scheen, A.J. (2020). DPP-4 inhibition and COVID-19: from initial concerns to recent expectations. Diabetes Metab. 47: 101213.10.1016/j.diabet.2020.11.005Search in Google Scholar PubMed PubMed Central

Schnabel, R., Bernstein, H.G., Luppa, H., Lojda, Z., and Barth, A. (1992). Aminopeptidases in the circumventricular organs of the mouse brain: a histochemical study. Neuroscience 47: 431–438, https://doi.org/10.1016/0306-4522(92)90257-3.Search in Google Scholar PubMed

Seong, J.M., Yee, J., and Gwak, H.S. (2019). Dipeptidyl peptidase-4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: a nationwide population-based cohort study. Br. J. Clin. Pharmacol. 85: 1719–1727, https://doi.org/10.1111/bcp.13955.Search in Google Scholar PubMed PubMed Central

Shu, L., Liu, Y., Li, J., Wu, X., Li, Y., and Huang, H. (2021). Landscape profiling analysis of DPP4 in malignancies: therapeutic implications for tumour patients with coronavirus disease. Front. Oncol. 11: 624899, eCollection 2021, https://doi.org/10.3389/fonc.2021.624899.Search in Google Scholar PubMed PubMed Central

Siddiqui, N., Ali, J., Zameer, S., Najmi, A.K., and Akhtar, M. (2021). Linagliptin, a DPP-4 inhibitor, ameliorates Aß (1-42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1(IRS-1) in rat models of Alzheimer’s disease. Neuropharmacology 195: 108662.10.1016/j.neuropharm.2021.108662Search in Google Scholar PubMed

Sim, A.Y., Barua, S., Kim, J.Y., Lee, Y.H., and Lee, J.E. (2021). Role of DPP-4 and SGLT2 inhibitors connected to Alzheimer disease in type 2 diabetes mellitus. Front. Neurosci. 15: 708547, eCollection 2021, https://doi.org/10.3389/fnins.2021.708547.Search in Google Scholar PubMed PubMed Central

Smyth, M. and O’Cuinn, G. (1994). Dipeptidyl aminopeptidase activities of Guinea-pig brain. Int. J. Biochem. 26: 913–921, https://doi.org/10.1016/0020-711x(94)90085-x.Search in Google Scholar PubMed

Solerte, S.B., Di Sabatino, A., Galli, M., and Fiorina, P. (2020). Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19. Acta Diabetol. 57: 779–783, https://doi.org/10.1007/s00592-020-01539-z.Search in Google Scholar PubMed PubMed Central

Sridhar, G.R., Lakshmi, G., and Nagamani, G. (2015). Emerging links between type 2 diabetes and Alzheimer’s disease. World J. Diabetes 6: 744–751, https://doi.org/10.4239/wjd.v6.i5.744.Search in Google Scholar PubMed PubMed Central

Srinivas, N.R. (2015). Linagliptin-Role in the reversal of Aβ-mediated impairment of insulin signaling and reduced neurotoxicity in AD pathogenesis: some considerations. CNS Neurosci. Ther. 21: 962–963.10.1111/cns.12475Search in Google Scholar PubMed PubMed Central

Steinbrecher, A., Reinhold, D., Quigley, L., Gado, A., Tresser, N., Izikson, L., Born, I., Faust, J., Neuber, K., Martin, R., et al.. (2001). Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo. J. Immunol. 166: 2041–2048, https://doi.org/10.4049/jimmunol.166.3.2041.Search in Google Scholar PubMed

Stremenová, J., Mares, V., Lisá, V., Hilser, M., Krepela, E., Vanicková, Z., Syrucek, M., Soula, O., and Sedo, A. (2010). Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas. Int. J. Oncol. 36: 351–358.10.3892/ijo_00000506Search in Google Scholar

Stremenova, J., Krepela, E., Mares, V., Trim, J., Dbaly, V., Marek, J., Vanickova, Z., Lisa, V., Yea, C., and Sedo, A. (2007). Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade. Int. J. Oncol. 31: 785–792, https://doi.org/10.3892/ijo.31.4.785.Search in Google Scholar

Strollo, R. and Pozzilli, P. (2020). DPP4 inhibition: preventing SARS-2 infection and/or progression of COVID-19? Diabetes Metab. Res. Rev. 36: e3330, https://doi.org/10.1002/dmrr.3330.Search in Google Scholar PubMed PubMed Central

Su, X., Li, W., Lv, L., Li, X., Yang, J., Luo, X.J., and Liu, J. (2021). Transcriptome-wide association study provides insights into the genetic component of gene in anxiety. Front. Genet. 12: 740134, eCollection 2021.10.3389/fgene.2021.740134Search in Google Scholar PubMed PubMed Central

Sun, Q., Zhang, Y., Huang, J., Yu, F., Xu, J., Peng, B., Liu, W., Han, S., Yin, J., and He, X. (2017). DPP4 regulates the inflammatory response in a rat model of febrile seizures. Bio Med. Mater. Eng. 28: S139–S152, https://doi.org/10.3233/bme-171635.Search in Google Scholar

Svenningsson, P., Wirdefeldt, K., Yin, L., Fang, F., Markaki, I., Efendic, S., and Ludvigsson, J.F. (2016). Reduced incidence of Parkinson’s disease after dipeptidyl peptidase-4 inhibitors-A nationwide case-control study. Mov. Disord. 31: 1422–1423, https://doi.org/10.1002/mds.26734.Search in Google Scholar PubMed

Tejera-Alhambra, M., Casrouge, A., de Andrés, C., Ramos-Medina, R., Alonso, B., Vega, J., Albert, M.L., and Sánchez-Ramón, S. (2014). Low DPP4 expression and activity in multiple sclerosis. Clin. Immunol. 150: 170–183, https://doi.org/10.1016/j.clim.2013.11.011.Search in Google Scholar PubMed

Torices, S., Cabrera, R., Stangis, M., Naranjo, O., Fattakhov, N., Teglas, T., Adesse, D., and Toborek, M. (2021). Expression of SARS-CoV-2-related receptors in cells of the neurovascular unit: implications for HIV-1 infection. J. Neuroinflammation 18: 167, https://doi.org/10.1186/s12974-021-02210-2.Search in Google Scholar PubMed PubMed Central

Trenkwalder, P. and Rüchardt, A. (2015). Primär-und Sekundärprevention des [Primary and secondary prevention of stroke] German. Dtsch. Med. Wochenschr. 140: 1593–1598.10.1055/s-0041-103118Search in Google Scholar

Trinh, J. and Farrer, M. (2013). Advances in the genetics of Parkinson disease. Nat. Rev. Neurol. 9: 445–454, https://doi.org/10.1038/nrneurol.2013.132.Search in Google Scholar PubMed

Valverde, A., Duny, J., Lorivel, T., Debayle, D., Gay, A.S., Caillava, C., Chami, M., and Checler, F. (2021a). Dipeptidyl peptidase 4 contributes to Alzheimer’s disease-like defects in a mouse model and is increased in sporadic Alzheimer’s disease brains. J. Biol. Chem. 297: 100963, https://doi.org/10.1016/j.jbc.2021.100963.Search in Google Scholar PubMed PubMed Central

Valverde, A., Dunys, J., Lorivel, T., Debayle, D., Gay, A.S., Lacas-Gervais, S., Roques, B.P., Chami, M., and Checler, F. (2021b). Aminopeptidase A contributes to biochemical, anatomical and cognitive defects in Alzheimer’s disease (AD) mouse model and is increased at early stage in sporadic AD brain. Acta Neuropathol. 141: 823–839, https://doi.org/10.1007/s00401-021-02308-0.Search in Google Scholar PubMed PubMed Central

Van Doremalen, N. and Munster, V.J. (2015). Animal models of Middle East respiratory syndrome coronavirus infection. Antiviral Res. 122: 28–38, https://doi.org/10.1016/j.antiviral.2015.07.005.Search in Google Scholar PubMed PubMed Central

Vankadari, N. and Wilce, J.A. (2020). Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg. Microb. Infect. 9: 601–604, https://doi.org/10.1080/22221751.2020.1739565.Search in Google Scholar PubMed PubMed Central

Van Langelaar, J., Rijvers, L., Smolders, J., and van Luijn, M.M. (2020). B and T cells driving: identity, mechanisms and potential triggers. Front. Immunol. 11: 760, eCollection 2020, https://doi.org/10.3389/fimmu.2020.00760.Search in Google Scholar PubMed PubMed Central

Van West, D., Monteleone, P., Di Lieto, A., De Meester, I., Durinx, C., Scharpe, S., Lin, A., Maj, M., and Maes, M. (2000). Lowered serum dipeptidyl peptidase IV activity in patients with anorexia nervosa and bulimia nervosa. Eur. Arch. Psychiatr. Clin. Neurosci. 250: 86–92, https://doi.org/10.1007/s004060070040.Search in Google Scholar PubMed

Vinti, V., Dell’Isola, G.B., Tascini, G., Mencaroni, E., Cara, G.D., Striano, P., and Verrotti, A. (2021). Temporallobeepilepsy and psychiatric comorbidity. Front. Neurol. 12: 775781, eCollection 2021, https://doi.org/10.3389/fneur.2021.775781.Search in Google Scholar PubMed PubMed Central

Vojdani, A., Bazargan, M., Vojdani, E., Samadi, J., Nourian, A.A., Eghbalieh, N., and Cooper, E.L. (2004). Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease. Clin. Diagn. Lab. Immunol. 11: 515–524, https://doi.org/10.1128/cdli.11.3.515-524.2004.Search in Google Scholar

Waldvogel, H.J., Thu, D., Hogg, V., Tippett, L., and Faull, R.L. (2012). Selective neurodegeneration, neuropathology and symptom profiles in Huntington’s disease. Adv. Exp. Med. Biol. 769: 141–152.10.1007/978-1-4614-5434-2_9Search in Google Scholar PubMed

Wang, C.H. and Zhu, N. (2019). Protective role of sitagliptin against oxidative stress in a kainic acid-induced status epilepticus in rats models via Nrf2/HO-1 pathways. Drug Dev. Res. 80: 446–452, https://doi.org/10.1002/ddr.21516.Search in Google Scholar PubMed

Wang, K., Lv, Z., Xu, P., Cui, Y., Zang, X., Zhang, D., and Wang, J. (2022). Factors related to the risk of stroke in the population with type 2 diabetes: a protocol for systematic review and meta-analysis. Medicine (Baltim.) 101: e27770, https://doi.org/10.1097/md.0000000000027770.Search in Google Scholar

Wang, Z., Fan, Y., Xu, J., Li, L., Heng, D., Han, S., Yin, J., Peng, B., Liu, W., and He, X. (2014). Transcriptome analysis of the hippocampus in novel rat model of febrile seizures. PLoS One 9: e95237, eCollection 2014, https://doi.org/10.1371/journal.pone.0095237.Search in Google Scholar PubMed PubMed Central

Wesley, U.V., Hatcher, J.F., Ayvaci, E.R., Klemp, A., and Dempsey, R.J. (2017). Regulation of dipeptidyl peptidase IV in the post-stroke rat brain and in vitro ischemia: implications for chemokine-mediated neural progenitor cell migration and angiogenesis. Mol. Neurobiol. 54: 4973–4985, https://doi.org/10.1007/s12035-016-0039-4.Search in Google Scholar PubMed PubMed Central

Wierzba-Bobrowicz, T., Krajewski, P., Tarka, S., Acewicz, A., Felczak, P., Stępień, T., Golan, M.P., and Grzegorczyk, M. (2021). Neuropathological analysis of the brains of fifty-two patients with COVID-19. Folia Neuropathol. 59: 219–231, https://doi.org/10.5114/fn.2021.108829.Search in Google Scholar PubMed

Wilczyńska, K., Simonienko, K., Konarzewska, B., Szajda, S.D., and Waszkiewicz, N. (2018). Morphological changes of the brain in mood disorders. Psychiatr. Pol. 52: 797–805, https://doi.org/10.12740/pp/89553.Search in Google Scholar PubMed

Yachou, Y., El Idrissi, A., Ait Benali, S., Belapasov, V., and Benali, S.A. (2020). Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol. Sci. 41: 2657–2669, https://doi.org/10.1007/s10072-020-04575-3.Search in Google Scholar PubMed PubMed Central

Yang, D., Nakajo, Y., Iihara, K., Kataoka, H., and Yanamoto, H. (2013). Alogliptin, a -4 inhibitor, for patients with diabetes mellitus type 2, induces tolerance to focal cerebral ischemia in non-diabetic, normal mice. Brain Res. 1517: 104–113.10.1016/j.brainres.2013.04.015Search in Google Scholar PubMed

Yang, Y., Cai, Z., and Zhang, J. (2021). DPP-4 inhibitors my improve the mortality of disease 2019. Plos One 16: e0251916, eCollection 2021.10.1371/journal.pone.0251916Search in Google Scholar PubMed PubMed Central

Yip, H.K., Lee, M.S., Li, Y.C., Shao, P.L., Chiang, J.Y., Sung, P.H., Yang, C.H., and Chen, K.H. (2020). Dipeptidyl peptidase-4 deficiency effectively protects the brain and neurological function in rodent after acute hemorrhagic stroke. Int. J. Biol. Sci. 16: 3116–3132, eCollection 2020, https://doi.org/10.7150/ijbs.42677.Search in Google Scholar PubMed PubMed Central

Zambotti-Villela, L., Yamasaki, S.C., Villarroel, J.C., Murena-Nunes, C., and Siveira, P.F. (2007). Prolyl, ans pyroglutamyl peptidase activities in the hippocampus and hypothalamus of streptozotocin-induced diabetic rats. Peptides 28: 1586–1595.10.1016/j.peptides.2007.07.012Search in Google Scholar PubMed

Zawadzka, A., Cieślik, M., and Adamczyk, A. (2021). The Role of maternal immune activation in the pathogenesis of Autism: a review of the evidence, proposed mechanisms and implications for treatment. Int. J. Mol. Sci. 22: 11516, https://doi.org/10.3390/ijms222111516.Search in Google Scholar PubMed PubMed Central

Zeberg, H. and Pääbo, S. (2020). The MERS-CoV receptor gene is among COVID-19 risk factors inherited from Neandertals. bioRxiv, https://doi.org/10.1100/2020.12.11.422139.Search in Google Scholar

Zhang, G., Kim, S., Gu, X., Yu, S.P., and Wie, L. (2020). DPP-4 Inhibitor linagliptin is neuroprotective in hyperglycemic mice with stroke via the AKT/mTOR pathway and anti-apoptotic effects. Neurosci. Bull. 36: 407–418, https://doi.org/10.1007/s12264-019-00446-w.Search in Google Scholar PubMed PubMed Central

Zhang, P., Huang, H., Gao, X., Jiang, J., Xi, C., Wu, L., Fu, Y., Lai, J., and Hu, S. (2021). Involvement of kynurenine metabolism in bipolar disorder: an updated review. Front. Psychiatr. 12: 677039, eCollection 2021, https://doi.org/10.3389/fpsyt.2021.677039.Search in Google Scholar PubMed PubMed Central

Zhang, Y., Liu, Y., Xu, J., Sun, Q., Yu, F., Cheng, J., Peng, B., Liu, W., Xiao, Z., Han, S., et al.. (2018). Inhibition of DPP4 enhances inhibitory synaptic transmission through activating the GLP-1/GLP-1R signaling pathway in a rat model of febrile seizures. Biochem. Pharmacol. 156: 78–85, https://doi.org/10.1016/j.bcp.2018.08.004.Search in Google Scholar PubMed

Zheng, T., Gao, Y., Baskota, A., Chen, T., Ran, X., and Tian, H. (2014). Increased plasma DPP4 activity is predictive of prediabetes and type 2 diabetes onset in Chinese over a four-year period: result from the China National Diabetes and Metabolic Disorders Study. J. Clin. Endocrinol. 99: E2330–E2334.10.1210/jc.2014-1480Search in Google Scholar PubMed

Zheng, T., Ge, B., Quin, L., Chen, B., Tian, B., Gao, Y., Xiao, L., Hu, X., Pan, H., and Chen, Y. (2020). Association of plasma DPP4 activity and brain-derived neurotrophic factor with moderate to severe depressive symptoms in patients with type 2 diabetes: results from a cross-sectional study. Psychosom. Med. 82: 350–358, https://doi.org/10.1097/psy.0000000000000796.Search in Google Scholar

Zubkov, E.A., Zorkina, Y.A., Orshanskaya, E.V., Khlebnikova, N.N., Krupina, N.A., and Chekhonin, V.P. (2017). Changes in gene expression profiles in adult rat brain structures after neonatal action of dipeptidyl peptidase-IV inhibitors. Neuropsychobiology 76: 89–99, https://doi.org/10.1159/000488367.Search in Google Scholar PubMed

Zumla, A., Hui, D.S., and Perlman, S. (2015). Middle East respiratory syndrome. Lancet 386: 995–1007, https://doi.org/10.1016/s0140-6736(15)60454-8.Search in Google Scholar PubMed PubMed Central